NCT02182453View on ClinicalTrials.gov

Single Rising Oral Doses of BI 10773 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2008

Conditions
Healthy
Interventions
DRUG

BI 10773 - single rising dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY